Crear Jara, Singalavanija Tassapol, Juntipwong Sarinee, Tiu Teo Honeylen M, Zacharek Mark, Demirci Hakan
Kellogg Eye Center, Department of Ophthalmology and Visual Science, University of Michigan, Ann Arbor, Michigan, USA.
Department of Ophthalmology, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
Orbit. 2025 Feb;44(1):18-23. doi: 10.1080/01676830.2024.2375317. Epub 2024 Aug 1.
To evaluate the results of a minimally invasive combined endoscopic and eyelid crease/medial suprabrow incision approach in collaboration with oculoplastic and sinus surgeons for the treatment of recurrent/recalcitrant sino-orbital mucoceles.
Eighteen cases of recurrent/recalcitrant sino-orbital mucoceles, treated in collaboration with oculoplastic and sinus surgeons at the University of Michigan, were retrospectively reviewed. The recurrence of mucocele, reduction in proptosis, and complications were evaluated.
The mean age at the time of surgery was 49 years (range: 17-76 years). All cases had a history of previous sinus or orbital surgeries for mucoceles. Among 18 cases, eight were due to chronic sinus infections, six due to trauma, three due to Schneiderian papilloma, and one case was secondary to an inflammatory sinus disease. Thirteen cases (72%) presented with orbital or facial cellulitis, while five cases (38%) experienced periocular swelling and limited extraocular motility. Following a mean follow-up of 19 months (range: 1-76 months)), recurrence was observed in two cases (11%): one in a cystic fibrosis patient with chronic sinusitis, and the other in a case of Schneiderian papilloma. The mean pre-operative proptosis in the affected eye was 2.78 mm, with an average decrease of 2.33 mm after surgery. Complications occurred in two cases, including one case of hypoesthesia in the forehead and one case of post-operative strabismus.
Our series of 18 cases of recurrent/recalcitrant mucoceles, with only two cases of recurrence, demonstrates that this minimally invasive approach can be successfully employed for advanced sino-orbital disease, with a low rate of adverse outcomes and aesthetically pleasing results.
评估一种微创联合内镜及眼睑皱襞/眉上内侧切口入路,与眼整形和鼻窦外科医生合作治疗复发性/难治性鼻窦眼眶黏液囊肿的效果。
回顾性分析18例在密歇根大学与眼整形和鼻窦外科医生合作治疗的复发性/难治性鼻窦眼眶黏液囊肿病例。评估黏液囊肿的复发情况、眼球突出度的降低情况及并发症。
手术时的平均年龄为49岁(范围:17 - 76岁)。所有病例既往均有因黏液囊肿进行鼻窦或眼眶手术的病史。18例中,8例因慢性鼻窦感染,6例因外伤,3例因内翻乳头状瘤,1例继发于炎症性鼻窦疾病。13例(72%)出现眼眶或面部蜂窝织炎,5例(38%)有眼周肿胀及眼球运动受限。平均随访19个月(范围:1 - 76个月)后,2例(11%)复发:1例为患有慢性鼻窦炎的囊性纤维化患者,另1例为内翻乳头状瘤患者。患眼术前平均眼球突出度为2.78mm,术后平均降低2.33mm。发生2例并发症,包括1例前额感觉减退和1例术后斜视。
我们这组18例复发性/难治性黏液囊肿病例,仅2例复发,表明这种微创入路可成功用于治疗晚期鼻窦眼眶疾病,不良后果发生率低且美容效果良好。